Ceribell

United States
Plain, Wisconsin, United States, 94043

Company profile

Ceribell company profile

Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective. The company creates and validates an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision-making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.

Business identity

Contact email
[email protected]
Phone number
+1 800-763-0183
Operating status
Active
Company type
For Profit
Employee range
251-500 employees
Revenue range
$50,000+
Founded
2014-01-01, Year

Headquarters

Postal code
94043
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$151M
Last funding
Series C / $50M / 2022-09-21
Last equity funding
Series C / $50M
Investors
12
Lead investors
5
Founders
3
Articles
138
Exited on
2024-10-11

Founders and investors

Founders

Chris ChafeJosef ParviziXingjuan Chao

Lead investors

Ally Bridge GroupHorizon Technology FinanceLongitude CapitalOptimas Capital Partners FundThe Rise Fund

Investors

Ally Bridge GroupLongitude CapitalRA Capital ManagementRedmile GroupThe Rise Fund